Acetaminophen and codeine phosphate and Cymbalta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acetaminophen and codeine phosphate (acetaminophen; codeine phosphate) and Cymbalta (duloxetine hydrochloride). Common drug interactions include agitation among females and cellulitis among males.

The phase IV clinical study analyzes what interactions people have when they take Acetaminophen and codeine phosphate and Cymbalta. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Acetaminophen and codeine phosphate?

Acetaminophen and codeine phosphate has active ingredients of acetaminophen; codeine phosphate. It is often used in pain. eHealthMe is studying from 3,220 Acetaminophen and codeine phosphate users. Check the latest studies of Acetaminophen and codeine phosphate.

What is Cymbalta?

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 154,974 Cymbalta users. Check the latest studies of Cymbalta.



On Aug, 01, 2026

25 people who take Acetaminophen and codeine phosphate and Cymbalta together, and have interactions are studied.

Acetaminophen and codeine phosphate and Cymbalta drug interactions.

What are the common drug interactions of Acetaminophen And Codeine Phosphate and Cymbalta, by gender? *:

female:

  1. Agitation (state of anxiety or nervous excitement)
  2. Chest pain
  3. Headache (pain in head)
  4. Insomnia (sleeplessness)
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  6. Activities of daily living impaired
  7. Hyperreflexia (overactive or over responsive reflexes)
  8. Muscular weakness (muscle weakness)
  9. Neck pain
  10. Pain in extremity

male:

  1. Cellulitis (infection under the skin)
  2. Colon adenoma (non cancerous epithelial colon tumour having a glandular origin and structure)
  3. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  4. Iron deficiency anaemia
  5. Oedema peripheral (superficial swelling)
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  9. Skin ulcer
  10. Venous insufficiency (poor circulation of blood caused by damaged or enlarged veins)

What are the common drug interactions of Acetaminophen And Codeine Phosphate and Cymbalta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Neuralgia (pain in one or more nerves)
  2. Hyperaesthesia
  3. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins)
  4. Insomnia (sleeplessness)
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

30-39:

  1. Activities of daily living impaired
  2. Agitation (state of anxiety or nervous excitement)
  3. Chest pain
  4. Hyperreflexia (overactive or over responsive reflexes)
  5. Muscular weakness (muscle weakness)
  6. Neck pain
  7. Pain in extremity
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  9. Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
  10. Hepatitis (inflammation of the liver)

40-49:

  1. Agitation (state of anxiety or nervous excitement)
  2. Headache (pain in head)
  3. Insomnia (sleeplessness)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Alanine aminotransferase increased
  6. Aspartate aminotransferase increased
  7. Red blood cell sedimentation rate increased
  8. Weight increased

50-59:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Bone marrow failure
  3. Cellulitis (infection under the skin)
  4. Colon adenoma (non cancerous epithelial colon tumour having a glandular origin and structure)
  5. Drug effect decreased
  6. Erosive oesophagitis (acid reflux disease can cause tissue damage in the oesophagus over time)
  7. Fall
  8. Femur fracture
  9. Gastric antral vascular ectasia (blood vessels in the lining of the stomach become fragile and become prone to rupture and bleeding)
  10. Gastric ulcer (stomach ulcer)

60+:

  1. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  2. Suicidal ideation
  3. Death
  4. Decreased interest
  5. Dehydration (dryness resulting from the removal of water)
  6. Diabetic complication
  7. Diabetic gastroparesis (paralysis of the muscles of the stomach caused by diabetes)
  8. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  9. Dyspnoea (difficult or laboured respiration)
  10. Emotional disorder

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 20.00%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 12.00%
  3. Psoriasis (immune-mediated disease that affects the skin): 3 people, 12.00%
  4. Osteoporosis (bones weak and more likely to break): 3 people, 12.00%
  5. High Blood Pressure: 3 people, 12.00%
  6. Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 12.00%
  7. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 3 people, 12.00%
  8. Diabetes: 3 people, 12.00%
  9. Stress And Anxiety: 2 people, 8.00%
  10. Migraine (headache): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Acetaminophen and codeine phosphate and Cymbalta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acetaminophen and codeine phosphate and Cymbalta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acetaminophen and codeine phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cymbalta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acetaminophen and codeine phosphate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cymbalta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; codeine phosphate and duloxetine hydrochloride (the active ingredients of Acetaminophen and codeine phosphate and Cymbalta, respectively), and Acetaminophen and codeine phosphate and Cymbalta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: